MX2018002032A - Methods and compositions using bifidobacterium longum to optimize breastfeeding. - Google Patents

Methods and compositions using bifidobacterium longum to optimize breastfeeding.

Info

Publication number
MX2018002032A
MX2018002032A MX2018002032A MX2018002032A MX2018002032A MX 2018002032 A MX2018002032 A MX 2018002032A MX 2018002032 A MX2018002032 A MX 2018002032A MX 2018002032 A MX2018002032 A MX 2018002032A MX 2018002032 A MX2018002032 A MX 2018002032A
Authority
MX
Mexico
Prior art keywords
breastfeeding
optimize
compositions
methods
bifidobacterium longum
Prior art date
Application number
MX2018002032A
Other languages
Spanish (es)
Inventor
Bergonzelli Gabriela
Rochat Florence
Bergonzelli Degonda Gabriela
ALVES NUNES Tiago
Marquardt Valerie
Antonius Johannes Schmitt Jeroen
HAUSER Jonas
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018002032A publication Critical patent/MX2018002032A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

B. longum ATCC BAA-999, or a composition comprising B. longum ATCC BAA-999, for use in an individual to; support breastfeeding initiation and/or to optimise breastfeeding duration and/or to optimize the quality and/or quantity ofbreast milk and/or to prevent or treat peripartum emotional distress and/or to regulate amygdala activity and/or to regulate the release of CRH, and to prevent or treat the negative effects of peripartum emotional distress in the offspring of individuals.
MX2018002032A 2015-08-31 2016-08-31 Methods and compositions using bifidobacterium longum to optimize breastfeeding. MX2018002032A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562212148P 2015-08-31 2015-08-31
US201562220408P 2015-09-18 2015-09-18
US201562220414P 2015-09-18 2015-09-18
US201562236638P 2015-10-02 2015-10-02
US201562236639P 2015-10-02 2015-10-02
PCT/EP2016/070496 WO2017037105A1 (en) 2015-08-31 2016-08-31 Methods and compositions using bifidobacterium longum to optimize breastfeeding

Publications (1)

Publication Number Publication Date
MX2018002032A true MX2018002032A (en) 2018-04-13

Family

ID=56852263

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002032A MX2018002032A (en) 2015-08-31 2016-08-31 Methods and compositions using bifidobacterium longum to optimize breastfeeding.

Country Status (7)

Country Link
EP (1) EP3344269A1 (en)
CN (1) CN107980002A (en)
BR (1) BR112018001179A2 (en)
CA (1) CA2994352A1 (en)
MX (1) MX2018002032A (en)
PH (1) PH12018500117A1 (en)
WO (1) WO2017037105A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018014559A (en) * 2016-07-01 2019-03-28 Nestec Sa Nutritional composition comprising a probiotic for the prevention and/or treatment of anxiety disorders and related conditions in a mammal.
TW201924696A (en) * 2017-12-01 2019-07-01 瑞士商耐斯泰克公司 Maternal supplement
CN111165828A (en) * 2020-03-24 2020-05-19 西安交通大学医学院第一附属医院 Composition and health food for promoting milk secretion
WO2024158981A1 (en) * 2023-01-26 2024-08-02 Wisconsin Alumni Research Foundation Compositions and methods for reducing the rate of type 1 diabetes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101095698B (en) * 2006-06-26 2010-12-01 青岛东海药业有限公司 Use of Clostridium Butyricum for preventing and treating foetid faeces toxin syndrome and disease
EP2110028A1 (en) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
AU2009319257B2 (en) * 2008-11-03 2014-10-09 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
TR201807143T4 (en) * 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum and functional gastrointestinal disorders.
CA2779418C (en) * 2009-11-11 2018-03-20 Alimentary Health Limited Probiotic bifidobacterium strain
WO2015090349A1 (en) * 2013-12-16 2015-06-25 Nestec S.A. Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants

Also Published As

Publication number Publication date
WO2017037105A1 (en) 2017-03-09
CN107980002A (en) 2018-05-01
EP3344269A1 (en) 2018-07-11
PH12018500117A1 (en) 2018-07-23
CA2994352A1 (en) 2017-03-09
BR112018001179A2 (en) 2018-09-11

Similar Documents

Publication Publication Date Title
PH12018500117A1 (en) Methods and compositions using bifidobacterium longum to optimize breastfeeding
HK1248548A1 (en) Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
MX2019005127A (en) Mesenchymal stem cells populations, their products, and use thereof.
PH12017500680A1 (en) Compositions and methods of use for treating metabolic disorders
PH12017500153A1 (en) Compositions and methods of use for treating metabolic disorders
MX2019014009A (en) Improved methods for manufacturing adoptive cell therapies.
MX2015006491A (en) Synergistic bacterial compositions and methods of production and use thereof.
MX2017014787A (en) Bacterial populations for promoting health.
IL248451A0 (en) Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
WO2016090178A3 (en) Processes for producing exosomes in reduced oxygen culture conditions
MY187540A (en) Compounds active towards bromodomains
MX2019007890A (en) 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells.
MX2017006263A (en) Hybrid dairy cattle and systems for maximizing hybrid advantage.
MX2020005849A (en) Crispr-cas9 modified cd34+ human hematopoietic stem and progenitor cells and uses thereof.
SG10201900041VA (en) Meningococcus vaccines
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
SG11202107732XA (en) Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
MX2018005158A (en) Compounds for treatment of hypoproliferative disorders.
PH12017500018A1 (en) Myo-inositol and probiotics, and their use
MX2014012164A (en) Compositions containing probiotics and a bee pollen/clay complex, preparation method thereof and uses of same in nutrition and therapeutics.
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
HK1254739A1 (en) Enrich and amplify highly potent human mesenchymal stem cells from elderly cell populations
MX2016009056A (en) Compositions and methods for treatment of abnormal cell growth.
NZ732071A (en) Low sugar sperm media and compositions
EP3484496C0 (en) Methods and composition for producing and using immune cells and stem cells for cell-based therapies